General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
GlaxoSmithKline urged to pool its patents on HIV drugs
Leading UK and international organisations urge UK's largest drug company to pool patents on HIV medicines to help save millions of lives.
Challenges facing pharmacists
Quality, appropriate use and availability of medicines are global problems for pharmacists, says the president of FIP
In Katine, a Coke is easy to buy. Medicine isn't
In Uganda and across Africa people are dying of diseases such as malaria and TB because they can't get the drugs to treat them - Guardian UK
The struggle for access to essential medicines in East and Southern Africa
Short stories from East and Southern Africa about the difficulties that ordinary people face in accessing essential medicines.
What is causing drug shortages in Uganda?
Sandra Kiapi, of Action Group for Health, Human Rights and HIV/AIDS (AGHA) Uganda, examines the problems in getting the right medicines to the right people at the right time.
Access, quality, transparency and accountability in the health care market place in Uganda
Health care in Uganda in the context of research studies on health rights with a special focus on HIV/AIDS and human rights in sub-Saharan Africa
Procurement of contraceptives in Latin America and the Caribbean
This report summarises experiences and lessons learned while facing new procurement challenges in 14 countries in the Latin American and Caribbean region.
Merck follows up GSK challenge by donating malaria drug to non-profit group
Merck is donating an experimental anti-malarial medicine to a not-for-profit research organisation - Reuters
Novartis supports access to medicines in the Philippines
Novartis to look at ways to "improve patient access to breakthrough medicines, preventive vaccines and diagnostics, over-the-counter medicines and high-quality generics".
GlaxoSmithKline announces price cuts and patent sharing
GlaxoSmithKline will share more than 800 drug patents with others hunting new cures for neglected tropical diseases and reduce the price of more than 110 medicines - Reuters.